In outlining shrinking methods for the treatment of perennial nasal obstructions we should like to emphasize that in cases of inflammatory or allergic disease of the nasal mucosa a causative factor or an immunobiologic basis should first be considered. Therefore, only those patients are selected for a shrinking treatment of the nasal mucosa on whom tests have first been made for nasal allergy and the reaction found to be negative or in whom clinical findings have excluded a sinus disease. The patients tested for allergy are those with "boggy" mucosa, ranged into the group of patients with vasomotor rhinitis or with muscular dystonia of the cavernous bodies; in the group examined for sinus disease are found true hyperplasia and hypertrophy of the mucous membrane, both causing recurrent or permanent attacks of nasal intumescence.
Various methods for reducing the size of the turbinates have been recommended. Since surface applications of chemical
TAMARI M, BUSBY W. EVALUATION OF SUBMUCOSAL SHRINKING METHODS FOR CHRONIC NASAL OBSTRUCTIONS. Arch Otolaryngol. 1944;39(4):331–333. doi:10.1001/archotol.1944.00680010345008